https://www.businesswire.com/news/home/20260606758364/en/Corcept-Presents-New-Data-at-ADA-Improved-Outcomes-in-Patients-Receiving-a-GLP-1-with-Difficult-to-Control-Type-2-Diabetes-and-Hypercortisolism-Treated-with-Korlym 2026-06-06T20:45:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260605975728/en/SES-AI-Corporation-Class-Action-Reminder---Robbins-LLP-Encourages-SES-Investors-to-Contact-the-Firm-for-Information-About-Their-Rights 2026-06-06T19:03:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260606323066/en/Dexcom-CONNECT-Study-The-Most-Significant-Clinical-Study-Demonstrating-CGM-Benefits-for-People-with-Type-2-Diabetes-Not-Using-Insulin 2026-06-06T18:45:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260606933094/en/Kalloghlian-Myers-LLP-Potential-Investor-Class-Action-Against-TerraVest-Industries-Inc. 2026-06-06T14:44:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260605120877/en/Robust-Phase-2b-Efficacy-and-Favorable-Tolerability-Support-Monthly-Dosing-for-Pfizers-GLP-1-RA-Berobenatide 2026-06-06T13:00:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260606260055/en/Insulet-Reveals-New-Data-Supporting-Breakthrough-Omnipod-6-and-Fully-Closed-Loop-AID-Systems-Designed-to-Improve-Outcomes-Reduce-Effort-and-Unlock-Barriers-to-Care 2026-06-06T11:00:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260603213405/it 2026-06-06T04:52:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260603213115/ja 2026-06-06T04:52:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260603076865/es 2026-06-06T04:52:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260604501773/it 2026-06-06T04:52:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260603451921/pt 2026-06-06T04:52:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260603667966/de 2026-06-06T04:52:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260603631543/nl 2026-06-06T04:51:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260603616248/fr 2026-06-06T04:51:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260603106141/zh-HK 2026-06-06T04:51:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260603028633/zh-CN 2026-06-06T04:51:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260605077979/en/Investor-Notice-Robbins-LLP-Informs-Investors-of-the-PicS-N.V.-Class-Action 2026-06-06T01:44:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260605832810/zh-HK 2026-06-06T01:00:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260605316929/en/Command-the-Clone-Wars-Most-Cunning-Operatives-in-Star-Wars-Zero-Company-Launching-August-27 2026-06-06T01:00:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260605667759/en/FINAL-FANTASY-VII-REVELATION-Announced-Experience-the-Journeys-End-in-Spring-2027 2026-06-06T00:40:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260605299292/zh-CN 2026-06-06T00:36:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260605404410/pt 2026-06-06T00:31:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260605053764/ja 2026-06-06T00:25:00.000Z weekly 0.5